These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11225257

  • 1. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
    Stehouwer CD.
    Ned Tijdschr Geneeskd; 2001 Jan 13; 145(2):61-4. PubMed ID: 11225257
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ.
    J Gynecol Obstet Biol Reprod (Paris); 1996 Jan 13; 25(7):671-6. PubMed ID: 8991899
    [Abstract] [Full Text] [Related]

  • 3. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Jan 13; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan 13; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 5. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators.
    Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec 01; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
    Antonicelli R, Olivieri F, Morichi V, Urbani E, Mais V.
    Int J Cardiol; 2008 Nov 12; 130(2):140-6. PubMed ID: 18617278
    [Abstract] [Full Text] [Related]

  • 19. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 12; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 20. HRT and the primary prevention of cardiovascular disease.
    Stevenson JC.
    Maturitas; 2007 May 20; 57(1):31-4. PubMed ID: 17383835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.